Table 2.
Multivariable Cox Regression Analyses for OS After POD, Adjusted for POD24.
| OS | ||||||
|---|---|---|---|---|---|---|
| N | Adjustment | HR | 95% CI, Lower | 95% CI, Upper | P | |
| At relapse | ||||||
| MIPI | 82 | None | 2.68 | 1.75 | 4.11 | <0.0001 |
| POD24 | 2.36 | 1.53 | 3.65 | 0.0001 | ||
| Ki67 >30% | 41 | None | 3.66 | 1.46 | 9.16 | 0.006 |
| POD24 | 2.90 | 1.10 | 7.65 | 0.032 | ||
| At diagnosis | ||||||
| MIPI | 147 | None | 2.03 | 1.63 | 2.54 | <0.0001 |
| POD24 | 1.86 | 1.48 | 2.34 | <0.0001 | ||
| Ki67 >30% | 128 | None | 2.25 | 1.48 | 3.42 | 0.0001 |
| POD24 | 1.87 | 1.22 | 2.87 | 0.004 | ||
| Blastoid | 149 | None | 3.21 | 2.07 | 4.98 | <0.0001 |
| POD24 | 2.84 | 1.80 | 4.49 | <0.0001 | ||
| TP53 mutations | 92 | None | 2.81 | 1.67 | 4.73 | 0.0001 |
| POD24 | 1.81 | 0.97 | 3.40 | 0.064 |
CI = confidence interval, HR = hazard ratio, Ki67 = cell proliferation marker, MIPI = mantle cell lymphoma international prognostic index, OS = overall survival, POD24 = progression of disease before 24 mo from start of frontline treatment.